Case Spotlight: Mexican Government Bonds Antitrust Settlement

2 August 2021

Case Background: The District Court preliminarily approved a $20.7M partial settlement of federal antitrust and common law claims against Barclays and J.P. Morgan (the “Settling Defendants”). Plaintiffs will continue litigation against the remaining non-settling defendants (the “Non-Settling Defendants”).[1] Plaintiffs allege that the defendants were the sole market makers for Mexican Government Bonds (“MGBs”) issued by the Mexican government through the Continue Reading

Blockchains and Future Litigation Funding

7 May 2021

Litigation funding has recently been a hot topic around the world. In this post, we explore how a new crypto approach could turn traditional funding on its head. In December 2020, Ava Labs (www.avalabs.org) announced the first Initial Litigation Offering (ILO) through Avalanche, “an open-source platform for launching highly decentralized applications, new financial primitives, and new interoperable blockchains.” I won’t Continue Reading

What Can Investors Learn from the Zimmer Bio Settlement Administration?

30 April 2021

On December 14, 2020, the US District Court for the Northern District of Indiana ordered the distribution of net settlement funds in the securities class action against Zimmer Biomet Holdings, Inc., a local medical device company. Claimants received payouts in February 2021. The briefing in support of final distribution offers investors insights into the administration, including the predominance of third-party Continue Reading

Get a monthly update with the latest industry developments related to U.S. Settled, non-U.S. opt-in, global passive and antitrust actions and recovery opportunities